OS Therapies
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -124 | -124 | -124 | -112 |
EBITDA | -10,043 | -13,335 | -6,754 | -4,424 |
EBIT | -10,167 | -13,460 | -6,879 | -4,536 |
Net Income | -10,396 | -13,460 | -6,879 | -4,536 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,563 | -3,730 | -4,706 | -2,676 |
Cash | 917,552 | 269,830 | 1,876 | 2,802 |
Basic Shares | 38,674 | 29,253 | 31,956 | 25,114 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -363 | -2 | -4 | |
EBITDA | -28,390 | -6,828 | -4,338 | -4,445 |
EBIT | -28,753 | -6,831 | -4,342 | -4,446 |
Net Income | -28,753 | -8,882 | -7,791 | -6,254 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,238,576 | -7,282 | -3,006 | -3,792 |
Cash | 269,830 | 5,533 | 38 | 171 |
Basic Shares | 29,253 | 20,869 | 20,049 | 23,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.36 |
2025-12-31 | -$0.41 |
2025-09-30 | -$0.21 |
2025-06-30 | -$0.18 |